SPTX (Seaport Therapeutics) Other Operating Expense: $ Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SPTX Seaport Therapeutics Inc SPTX
11 GF Score
Price $24.00
! 2 Warning Signs
View Full Analysis

What is Seaport Therapeutics Other Operating Expense?

Seaport Therapeutics SPTX -0.17% 11 Other Operating Expense is $ Mil as of Dec. 2025. GuruFocus rates SPTX with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Seaport Therapeutics's Other Operating Expense for the six months ended in Dec. 2025 was $-0.00 Mil. Seaport Therapeutics does not have enough years/quarters to calculate its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025.

Seaport Therapeutics's quarterly Other Operating Expense increased from . 20 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil) but then declined from Dec. 2024 ($-0.00 Mil) to Dec. 2025 ($-0.00 Mil).

Seaport Therapeutics's annual Other Operating Expense increased from . 20 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil) but then declined from Dec. 2024 ($-0.00 Mil) to Dec. 2025 ($-0.00 Mil).

Seaport Therapeutics Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Seaport Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seaport Therapeutics Other Operating Expense Chart

Seaport Therapeutics Annual Data
Trend Dec24 Dec25
Other Operating Expense
-0.00 -0.00

Seaport Therapeutics Semi-Annual Data
Dec24 Dec25
Other Operating Expense -0.00 -0.00
SPTX
11GF Score
Seaport Therapeutics Inc SPTX
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seaport Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $ Mil mean?
Seaport Therapeutics (SPTX) has a Other Operating Expense of $ Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Seaport Therapeutics and its competitors.
Is Seaport Therapeutics' Other Operating Expense too high?
Seaport Therapeutics' current Other Operating Expense is $ Mil. Overall, Seaport Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Seaport Therapeutics' Other Operating Expense compare to SVRA and DRTS?
Seaport Therapeutics' Other Operating Expense of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Seaport Therapeutics and its competitors. Seaport Therapeutics's current Other Operating Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seaport Therapeutics stock overvalued right now?
Seaport Therapeutics (SPTX) has a current Other Operating Expense of $ Mil. The current Other Operating Expense is $ Mil. Seaport Therapeutics' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Seaport Therapeutics (SPTX), the current Other Operating Expense is $ Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Seaport Therapeutics Business Description

Address 101 Seaport Boulevard, Floor 12, Boston, MA, USA, 02210
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
11GF Score

Get the complete analysis for SPTX

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.00
Price